536 related articles for article (PubMed ID: 27986932)
1. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
Palmer KR; Tong S; Kaitu'u-Lino TJ
Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia.
Palmer K
Methods Mol Biol; 2018; 1710():27-37. PubMed ID: 29196992
[TBL] [Abstract][Full Text] [Related]
3. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
[TBL] [Abstract][Full Text] [Related]
4. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
[TBL] [Abstract][Full Text] [Related]
5. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ
Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
7. Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia.
Rowson S; Reddy M; De Guingand DL; Langston-Cox A; Marshall SA; da Silva Costa F; Palmer KR
Placenta; 2022 Mar; 120():73-78. PubMed ID: 35227983
[TBL] [Abstract][Full Text] [Related]
8. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
[TBL] [Abstract][Full Text] [Related]
9. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
10. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
[TBL] [Abstract][Full Text] [Related]
11. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
12. Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
Palmer KR; Kaitu'u-Lino TJ; Cannon P; Tuohey L; De Silva MS; Varas-Godoy M; Acuña S; Galaz J; Tong S; Illanes SE
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):635-639. PubMed ID: 27124553
[TBL] [Abstract][Full Text] [Related]
13. Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.
Szalai G; Romero R; Chaiworapongsa T; Xu Y; Wang B; Ahn H; Xu Z; Chiang PJ; Sundell B; Wang R; Jiang Y; Plazyo O; Olive M; Tarca AL; Dong Z; Qureshi F; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
PLoS One; 2015; 10(4):e0119547. PubMed ID: 25860260
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.
Kanasaki K; Palmsten K; Sugimoto H; Ahmad S; Hamano Y; Xie L; Parry S; Augustin HG; Gattone VH; Folkman J; Strauss JF; Kalluri R
Nature; 2008 Jun; 453(7198):1117-21. PubMed ID: 18469803
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
[TBL] [Abstract][Full Text] [Related]
18. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
19. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
Verlohren S; Stepan H; Dechend R
Clin Sci (Lond); 2012 Jan; 122(2):43-52. PubMed ID: 21929511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]